CAMBRIDGE, Mass., October 14, 2025 – Ellis Bio Inc., a genomics biotechnology company, announced the publication of a new bioRxiv preprint from the laboratory of its scientific founder, Professor Chuan He of The University of Chicago (UChicago)/Howard Hughes Medical Institute (HHMI), describes the Ultra-Mild Bisulfite Sequencing (UMBS) method. UMBS is the foundation of Ellis Bio’s SuperMethyl™ Max Bisulfite Conversion Kit, which provides highly accurate methylation detection while minimizing DNA damage.
Read the full article on the Ellis Bio Website
Share this page on social